to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
A Kauffman Foundation town hall meeting explored how the government, nonprofits and academic institutions could help enhance drug development and bring more effective drugs to market.
The Silicon Valley might not be the "friendliest" place to start your life science or digital health company. A small business survey released this month by the Kauffman Foundation and Thumbtack.com gave Austin, Virginia Beach, and Houston top honors as the friendliest cities for small businesses.
With Washington buzzing about the possibility of comprehensive immigration reform this year, a new Kauffman Foundation white paper showed how Startup Visas for foreign-born entrepreneurs could help jumpstart the economy.
The archetypal entrepreneur is a strapping 20-something. But we shouldn’t count out Baby Boomers as the next innovators.
Dane Stangler, senior analyst at the Kauffman Foundation, uncovered these facts in some recent Kauffman Foundation research:
Thanks to the movement of research and development to China and India, scientists there are quickly developing the ability to innovate and create their own intellectual property, according to a Kauffman Foundation study.
With immigrants in more than 40 percent of the cancer researcher slots at America’s top cancer institutes, these scientists are playing an integral role in improving cancer survival rates in the United States, according to a Kauffman Foundation-funded National Foundation for American Policy report released last month.
As a life science entrepreneur, you surely have ideas on how changing legal rules and policies could promote innovation and accelerate U.S. economic growth. The Kauffman Foundation, seeking suggestions on how to jumpstart the struggling economy, convened America’s leading legal scholars and social scientists to offer their thoughts.
With U.S. healthcare costs rising about 2.5 percent faster than inflation, there’s an urgent need to improve productivity and quality in American healthcare. A Kauffman Foundation report found that open access to medical data could help find that cost-benefit balance.
Because life sciences entrepreneurship thrives on harnessing new technologies, spurring innovation, and growing companies, the Kauffman Foundation met in 2003 with the Panel of Advisors on the Life Sciences to help advance those goals.
More than 6 percent of Inc. 500 firms work in the health and drug space, making it the No. 5 industrial sector for these fast-growing companies from 2005 to 2010. But these medical innovators aren’t all concentrated in the Silicon Valley.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.